Researcher
Patrick Pauwels
- Research Expertise:molecular oncopathology
- Keywords:ANATOMOPATHOLOGY, ONCOLOGY, Medicine
- Disciplines:Oncology not elsewhere classified
- Research techniques:Next gen seq, ddPCR, liquid and tissue biopsy NGS, immunohistochemie, FISH, organoids
- Users of research expertise:researchers in de field of oncology
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Oct 2009 → 31 Dec 2018
Projects
1 - 10 of 32
- RNA Processing for anti-cancer immunotherapy (CANCERNA).From1 Jun 2022 → TodayFunding: HORIZON.2.1 - Health
- Development of an innovative personalised CAR-NK cell therapy for pancreatic cancer.From1 Jan 2022 → TodayFunding: BOF - projects
- A novel photoelectrochemical detection technology for molecular cancer biomarkers.From1 Sep 2021 → 31 Oct 2022Funding: IOF - technology validation in lab
- Combining targeted therapy and immunotherapy to improve survival and quality of life of head and neck cancer patients.From1 Mar 2021 → TodayFunding: Nonprofit institution or equivalents
- Heterogeneity of HER2 amplification in breast cancer – the use of liquid biopsy to identify patients with discrepancies between primary tumor and metastatic lesionsFrom3 Mar 2020 → 2 Mar 2022Funding: Nonprofit institution or equivalents
- Urine as a liquid biopsy for early stage cancer detection.From1 Jan 2020 → 31 Dec 2023Funding: Baekeland
- Integrated Personalized & Precision Oncology Network (IPPON).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
- Leveraging patient-driven research to improve rational therapy selection in (ROS1+) non-small cell lung cancer.From1 Jan 2020 → 31 Dec 2021Funding: FWO Humanitarian research project Stand up against Cancer
- Preclinical investigation of immunotherapy and VEGF-targeted therapy in combination with voluntary exercise as novel treatment strategy for malignant pleural mesothelioma.From1 Nov 2019 → TodayFunding: Nonprofit institution or equivalents
- Targeting CD70-positive cancer-associated fibroblasts to improve chemotherapy and alleviate the immuno-suppressive tumor microenvironment in advanced colorectal cancer.From1 Jan 2019 → 31 Dec 2023Funding: Nonprofit institution or equivalents
Publications
31 - 40 of 248
- From macroscopy to ultrastructure(2022)
Authors: Peter Braubach, Christopher Werlein, Edith Plucinski, Mark P. Kuhnel, Annemiek Snoeckx, Tobias Welte, Axel Haverich, Florian P. Laenger, Sabine Dettmer, Patrick Pauwels, et al.
Pages: 1 - 7 - Recent advances of immune checkpoint inhibition and potential for (combined) TIGIT blockade as a new strategy for malignant pleural mesothelioma(2022)
Authors: Sophie Rovers, Patrick Pauwels, Jan van Meerbeeck, Evelien Smits, Elly Marcq
Pages: 1 - 17 - The prognostic impact of the immune signature in head and neck squamous cell carcinoma(2022)
Authors: Hasan Baysal, Vasiliki Siozopoulou, Hannah Zaryouh, Christophe Hermans, Ho Wa Lau, Hilde Lambrechts, Erik Fransen, Ines De Pauw, Julie Jacobs, Marc Peeters, et al.
Pages: 1 - 18 - Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphoma(2021)
Authors: Nicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser, Stephane Dalle, Marie Maerevoet, Jean-Marie Michot, Vincent Ribrag, Fritz Offner, Marie Beylot-Barry, Helene Moins-Teisserenc, et al.
- An open-label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma(2021)
Authors: Astrid De Meulenaere, Tijl Vermassen, David Creytens, Stijn De Keukeleire, Tim Delahaye, Philippe Deron, Frederic Duprez, Samson Fung, Patrick Pauwels, Liesbeth Ferdinande, et al.
Pages: 2300 - 2313 - Immune checkpoint inhibitory therapy in sarcomas(2021)
Authors: Vasiliki Siozopoulou, Karen Zwaenepoel, Annelies Van Beeck, Evelien Smits, Patrick Pauwels, Elly Marcq
- Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells(2021)
Authors: Christophe Deben, Laurie Freire Boullosa, An Wouters, Bart Cuypers, Kris Laukens, Filip Lardon, Patrick Pauwels
Pages: 233 - 243 - The search for an interesting partner to combine with PD-L1 blockade in mesothelioma(2021)
Authors: Elly Marcq, Jonas Van Audenaerde, Jorrit De Waele, Céline Merlin, Patrick Pauwels, Jan van Meerbeeck, Scott A. Fisher, Evelien Smits
- Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic(2021)
Authors: P. Hofman, M. Ilie, E. Chamorey, P. Brest, R. Schiappa, V. Nakache, M. Antoine, M. Barberis, H. Begueret, F. Bibeau, et al.
- GSDME and its role in cancer(2021)
Authors: Elke De Schutter, Lieselot Croes, Joe Ibrahim, Patrick Pauwels, Peter Vandenabeele, Guy Van Camp
Pages: 2872 - 2883
Patents
1 - 4 of 4
- Immunotherapy markers (Inventor)
- Cell-based therapeutics targeting CD70 (Inventor)
- Immunotherapy markers (Inventor)
- Immunotherapy Markers (Inventor)